Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Sadoff

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|June 1, 1996
Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11mkCH Schneider, K A Schmidt, D R Skillman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalentR A Kuschner, A F Trofa, R J Thomas, et al.
Lancet (London, England)|September 14, 1996
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial GroupF Nosten, C Luxemburger, D E Kyle, et al.
The Journal of Infectious Diseases|May 1, 1996
A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremiaA K Bhattacharjee, S M Opal, R Taylor, et al.
JAMA|September 8, 1993
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
Vaccine|March 11, 1991
Efficacy trial of a parenteral gonococcal pilus vaccine in menJ W Boslego, E C Tramont, R C Chung, et al.
Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.
Science (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.
Circulatory Shock|September 1, 1994
Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsisC J Fisher, S M Opal, S F Lowry, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|June 1, 1996
Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11mkCH Schneider, K A Schmidt, D R Skillman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalentR A Kuschner, A F Trofa, R J Thomas, et al.
Lancet (London, England)|September 14, 1996
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial GroupF Nosten, C Luxemburger, D E Kyle, et al.
The Journal of Infectious Diseases|May 1, 1996
A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremiaA K Bhattacharjee, S M Opal, R Taylor, et al.
JAMA|September 8, 1993
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
Vaccine|March 11, 1991
Efficacy trial of a parenteral gonococcal pilus vaccine in menJ W Boslego, E C Tramont, R C Chung, et al.
Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.
Science (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.
Circulatory Shock|September 1, 1994
Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsisC J Fisher, S M Opal, S F Lowry, et al.
Pageof 12